000			01570 a2200457 4500
005			20250513102953.0
264		0	_c19970203
008			199702s 0 0 eng d
022			_a0006-3223
024	7		_a10.1016/0006-3223(95)00432-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aSwift, R M
245	0	0	_aOndansetron alters human alcohol intoxication. _h[electronic resource]
260			_bBiological psychiatry _cSep 1996
300			_a514-21 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAffect _xdrug effects
650	0	4	_aAged
650	0	4	_aAlcohol Drinking _xdrug therapy
650	0	4	_aAlcoholic Intoxication _xdrug therapy
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCentral Nervous System Depressants _xpharmacokinetics
650	0	4	_aCross-Over Studies
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Interactions
650	0	4	_aEthanol _xpharmacokinetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOndansetron _xtherapeutic use
650	0	4	_aPsychomotor Performance _xdrug effects
650	0	4	_aPulse _xdrug effects
650	0	4	_aSerotonin Antagonists _xtherapeutic use
700	1		_aDavidson, D
700	1		_aWhelihan, W
700	1		_aKuznetsov, O
773	0		_tBiological psychiatry _gvol. 40 _gno. 6 _gp. 514-21
856	4	0	_uhttps://doi.org/10.1016/0006-3223(95)00432-7 _zAvailable from publisher's website
999			_c8872153 _d8872153